↑ Rising
Health
🔮 fades ✓
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
The FDA has approved Daraxonrasib, a new drug targeting RAS-mutant non–small-cell lung cancer and pancreatic cancer patients.